News
18h
Zacks.com on MSNIs the Options Market Predicting a Spike in HighPeak Energy Stock?
Investors in HighPeak Energy, Inc. HPK need to pay close attention to the stock based on moves in the options market lately.
Baidu's core search business continues to struggle, with declining online marketing revenue and increased competition from platforms like WeChat and Douyin.
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the ...
Crypto companies rush IPO timeline to capitalize on hot US market conditions as Wall Street banks reveal $15B pipeline before ...
Leverage Shares 2X Long UNH Daily ETF offers leveraged exposure to UnitedHealth's stock via derivative positions with mild basis risk. See why UNHG is a Buy.
T-minus one day — As investors across Wall Street anxiously await Fed Chair Powell’s speech Friday at Jackson Hole in Wyoming, stocks slipped Wednesday with the S&P 500 dropping 0.2 percent and the ...
The United States and the European Union on Thursday established a written framework for the trade deal agreed to on July 27. The terms include a 15% US tariff on most EU imports: These include autos, ...
Bessent went on to add in a further interview with CNBC he expects tariff revenues under President Trump to exceed his ...
Collaboration with Leading Provider of Rugged AI and Sensor Processing Platforms Strengthens Maris-Tech’s U.S. Market Reach ...
18h
TipRanks on MSN“Equity…at a Discounted Price” Intel Stock (NASDAQ:INTC) Plunges as Intel Taps Shareholders
While chip stock Intel ($INTC) was riding high on a big new infusion of cash from SoftBank ($SFTBY), the high proved to be a good exit point for a ...
From the genocidal seizure of Native American lands and the transatlantic slave trade to the systematic violence underlying free trade deals that dispossessed millions of subsistence and small-scale ...
23h
Zacks Investment Research on MSNAbbVie Rises 11.5% in a Month: Buy, Hold or Sell the Stock?
AbbVie’s ABBV stock has risen 11.5% in the past month, mainly due to its beat-and-raise performance in the second quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results